ABSTRACT. An investigation of the stem bark of Erythrophleum suaveolens (Guill. & Perr.) Brenan yielded the known amide norcassaide (1) and a new diterpenoid alkaloid named norerythrosuaveolide (2) which was characterized as 7β-hydroxy-7-deoxo-6-oxonorcassaide. The structures were established on the basis of one and two-dimensional 1 H and 13 C NMR spectral data. The compounds showed potent antimicrobial activities against bacteria and yeasts.
INTRODUCTION
Erythrophleum suaveolens (syn: Erythrophleum guineense) is a large tree belonging to the Caesalpiniaceae family [1] . The bark decoction is used as an emetic, anti-inflammatory and analgesic. It is also used to dress wounds, to treat chickenpox and gangrenous sores, and as an ordeal poison [2] . The bark decoction of this plant is well known by traditional medicine practitioners in the Congo, the Democratic Republic of Congo (Zaïre) and, especially, by those in the Central and Eastern provinces of Cameroon who use it empirically for several ailments, including cardiovascular diseases and various inflammations. As part of a systematic search for anti-fungal and antibacterial agents from natural sources, the bio-guided fractionation of the stem bark extract of E. suaveolens furnished a chloroform extract which exhibited significant anti-fungal activity against 2 yeasts (Candida albicans and C. krusei) and antibacterial activity against 10 bacterial species (Escherichia coli, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Proteus vulgaris, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Streptococcus faecalis, and Streptococcus pneumoniae). Further purification of this fraction led to the isolation of two compounds: the known amide, norcassaide (1) and a new diterpenoid alkaloid, norerythrosuaveolide (2) , which has been characterized as 7β-hydroxy-7-deoxo-6-oxonorcassaide. The present paper deals with the structure elucidation of these compounds as well as their antimicrobial activity. 
EXPERIMENTAL General
Melting points are uncorrected.
1 H NMR spectra were recorded at 400 and 500 MHz and 13 C NMR spectra at 100 and 125 MHz in methanol-d 4 using TMS as internal Standard. Sephadex was used for column chromatography (LH 20). Precoated silica gel plates (Merck, silica gel 60 F 254 , 0.25 mm) were used for TLC. 
Extraction, isolation and characterization
Air-dried and finely powdered stem bark of E. suaveolens (2 kg) was macerated in hexane (10 L) for 72 hours affording a hexane extract (15 g). The residual air-dried powder was treated with 10% aqueous NH 3 and macerated in CHCl 3 for 24 hours. After filtration and evaporation at reduced pressure, the resultant crude extract (90 g) was treated with 5% aq. HCl (3 L). The aqueous phase was made alkaline with aqueous NH 3 and extracted several times with CHCl 3 . The CHCl 3 fraction was washed with water and dried (MgSO 4 ). Evaporation of the solvent furnished a fluffy extract (7 g ). Half of this solid was chromatographed on Sephadex (LH 20) using CHCl 3 -MeOH (1:1) and collecting 100 mL fractions. Identical fractions (TLC) obtained on elution with CHCl 3 -MeOH (0.5:9.5) were combined and the solvent removed in vacuo. The resultant semi-solid was further purified by preparative chromatography using CHCl 3 -MeOH (0.5:9.5) as elution solvent giving crystaline 1 (62 mg) and 2 (87 mg). 
Norcassaide (1)
.
Antimicrobial assay
The antimicrobial activity of compounds 1 and 2 was studied using 12 microbial cultures belonging to 9 aerobic bacterial species (Escherichia coli LMP0101U, Staphylococcus aureus LMP0206U, Proteus vulgaris LMP0103, Klebsiella pneumoniae LMP0210U, Salmonella typhimurium LMP0413, Pseudomonas aeruginosa LMP0102U, Streptococcus faecalis (LMP0207U), Salmonella typhi LMP0209U and Streptococcus pneumoniae LMP0210U), one anaerobic bacterium (positive beta-lactamase, Neisseria gonorrhoeae LMP0412) and 2 Candida species (C. albicans LMP0204U and C. krusei LMP0311U). These strains were clinically isolated from the urogenital discharges of patients in the Centre Pasteur du Cameroun health institution and monitored in the Laboratory of the Applied Microbiology and Molecular Pharmacology (LMP) of the University of Yaoundé I. The strains were activated at 37 °C for 24 hours on nutrient agar (aerobic bacteria), Sabouraud glucose agar (fungi), or 48 hours on the Mueller Hinton agar supplemented with 1% polyvitex and 5% defribrinated sheep blood (MHAPB) in 10% CO 2 atmosphere for Neisseria gonorrhoeae. The antimicrobial activities (Table 2) were evaluated on the basis of the minimal inhibition concentration (MIC) by Agar hole diffusion method [3] in series for Neisseria gonorrhoeae, and the macrodilution method [4] for other microorganisms. As the molecules were insoluble in water, several other solvents were tested. It was found that phosphate buffer pH 4.4 and 4.7 gave optimal results respectively for compounds 2 and 1. These solvents were consequently used in testing. Gentamicin (Bacteria) and Nystatin (yeasts), diluted in water, were used as reference antibiotics.
RESULTS AND DISCUSSIONS
The crude chloroform extract, obtained from the stem bark of Erythrophleum suaveolens as described above was purified by chromatography to furnish the known amide norcassaide (1) and a closely related diterpenoid alkaloid 2.
Compound 2 was isolated as colourless crystals from chloroform (m.p. 204-205 °C) and gave positive Draggendorf's and Mayer's tests, suggesting the presence of nitrogen. The UV spectrum, λ max (nm, log ε): (254, 3.98) and (366, 4.14), was compatible with the presence of a substituted α,β-unsaturated carbonyl group, while the IR spectrum showed bands due to hydroxyl (3480 cm . A DEPT experiment revealed 18 carbon atoms attached to a total of 34 hydrogen atoms: 5 methyl, 6 methylene and 7 methine groups. Three of the carbons, a methylene (δ C 57.7) and two methines (δ C 74.8 and δ C 76.4), were oxygenated. The remaining three degrees of unsaturation suggested that 2 had a tricyclic diterpenoid skeleton as in 1.
The 1 H NMR spectrum of 2 (Table 1) showed a close similarity to that of 1 (Table 1 ) except for the presence of a singlet at δ H 2.24 (H-5) and a carbinol proton H-7 (δ H 3.96, d, J = 11 Hz) associated with a hydroxylated carbon C-7 (δ C 74.8). It was apparent that 2 had the same structure as 1 apart from the substitution of ring B. H-7 showed a diaxial coupling with H-8. Thus the hydroxyl group is beta [5] [6] [7] . As erythrosuavine in our earlier investigation on E. suaveolens [7] , the 7β-OH orientation could explain the observed deshielding effect on the C-20 methyl protons which appeared in 2 as a doublet (J = 7 Hz) at δ H 1.19 relative to 1 (δ H 1.04, J = 7 Hz). This observation confirmed the β-orientation of the C-20 methyl group located on C-14 in compound 2 instead of the α-orientation as in 1. The ketonic carbonyl group must be situated at C-6. HMBC correlations from H-5 (Scheme 1) to the carbons at δ C 209.6 (C-6), 36.2 (C-4), 74.8 (C-7), 44.0 (C-9) and 76.4 (C-3) confirmed the substitution pattern of ring B. The expected E configuration of the 13,18 double bond [5, [7] [8] [9] is evident from the deshielding effect of the side chain carbonyl function (δ C 168.8) of one of the two allylic protons (δ H 2.09 and 2.76) at C-12 (δ C 23.3). The two methylene proton signals at δ H 3.50 (t, J = 6 Hz) and 3.70 (t, J = 6 Hz) were clearly visible on the 1 H-1 H COSY spectrum as an isolated correlation system It is noteworthy that the signals of H-18, N-methyl, N-methylene and O-methylene groups were doubled, as expected, in both the 1 H and 13 C NMR spectra of 1 and 2 as a result of restricted rotation about the amide bond [10] . Hence, compound 1 is the known compound norcassaide [10, 11] while 2 is 7β-hydroxy-7-deoxo-6-oxonorcassaide, named norerythrosuaveolide, which to our knowledge has not previously been described in the literature. Compound 1 and 2 showed strong antimicrobial activities with a large spectrum of activity ( Table 2 ). The Minimum Inhibition Concentration (MIC) of compound 1 varied from 9.76 µg/mL (C. krusei) to 39.06 µg/mL (C. albicans) on yeasts and from 39.06 µg/mL (K. pneumoniae and N. gonorrhoeae) to 156.00 µg/mL (E. coli, P. aeruginosa, S. typhimurium and S. aureus) on bacteria. Those of compound 2 varied from 9.76 µg/mL (C. krusei) to 19.50 µg/mL (C. albicans) on yeasts and from 9.76 µg/mL (N. gonorrhoeae) to 312.50 µg/mL (S. typhimurium and S. aureus) on bacteria. It appears that the activity of compound 2 observed on N. gonorrhoeae is greater than those of Gentamicin and Nystatin for C. albicans and C. krusei. Compound 1 also exhibited a better antimicrobial activity on C. krusei than Nystatin. C. krusei appears to be the most sensitive fungi to compound 1 and 2 whereas N. gonorrhoeae is the most sensitive bacterial strain. 
